Molecular Oncology
Volume 2, Issue 4 , Pages 340-348 , December 2008

Nemosis of fibroblasts is inhibited by benign HaCaT keratinocytes but promoted by malignant HaCaT cells

  • Kati Räsänen

      Affiliations

    • Haartman Institute, POB 21, FI-00014 University of Helsinki, Finland
    • Corresponding Author InformationCorresponding author. Tel.: +358 9 1912 6608; fax: +358 9 1912 6491.
    • ,
  • Pertteli Salmenperä

      Affiliations

    • Haartman Institute, POB 21, FI-00014 University of Helsinki, Finland
    • ,
  • Marc Baumann

      Affiliations

    • Protein Chemistry Unit, Institute of Biomedicine/Anatomy, University of Helsinki, Helsinki, Finland
    • ,
  • Ismo Virtanen

      Affiliations

    • Institute of Biomedicine/Anatomy, POB 63, FI-00014 University of Helsinki, Finland
    • ,
  • Antti Vaheri

      Affiliations

    • Haartman Institute, POB 21, FI-00014 University of Helsinki, Finland

Received 5 August 2008 ,Revised 11 September 2008 ,Accepted 14 September 2008.

References 

  1. Atula S, Grenman R, Syrjanen S. Fibroblasts can modulate the phenotype of malignant epithelial cells in vitro. Exp. Cell Res. 1997;235:180–187
  2. Bachmeier BE, Boukamp P, Lichtinghagen R, Fusenig NE, Fink E. Matrix metalloproteinases-2,-3,-7,-9 and -10, but not MMP-11, are differentially expressed in normal, benign tumorigenic and malignant human keratinocyte cell lines. Biol. Chem. 2000;381:497–507
  3. Baglole CJ, Ray DM, Bernstein SH, Feldon SE, Smith TJ, Sime PJ, et al. More than structural cells, fibroblasts create and orchestrate the tumor microenvironment. Immunol. Invest. 2006;35:297–325
  4. Bizik J, Kankuri E, Ristimäki A, Taieb A, Vapaatalo H, Lubitz W, et al. Cell–cell contacts trigger programmed necrosis and induce cyclooxygenase-2 expression. Cell Death Differ. 2004;11:183–195
  5. Boccaccio C, Sabatino G, Medico E, Girolami F, Follenzi A, Reato G, et al. The MET oncogene drives a genetic programme linking cancer to haemostasis. Nature. 2005;434:396–400
  6. Cunha GR, Hayward SW, Wang YZ, Ricke WA. Role of the stromal microenvironment in carcinogenesis of the prostate. Int. J. Cancer. 2003;107:1–10
  7. De Wever O, Mareel M. Role of tissue stroma in cancer cell invasion. J. Pathol. 2003;200:429–447
  8. Delehedde M, Lyon M, Vidyasagar R, McDonnell TJ, Fernig DG. Hepatocyte growth factor/scatter factor binds to small heparin-derived oligosaccharides and stimulates the proliferation of human HaCaT keratinocytes. J. Biol. Chem. 2000;277:12456–12462
  9. Fukumura D, Xavier R, Sugiura T, Chen Y, Park EC, Lu N, et al Tumor induction of VEGF promoter activity in stromal cells. Cell. 1998;94:715–725
  10. Fusenig NE, Boukamp P. Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes. Mol. Carcinog. 1998;23:144–158
  11. Hinz B. Formation and function of the myofibroblast during tissue repair. J Invest. Dermatol. 2007;127:526–537
  12. Hinz B, Gabbiani G. Cell-matrix and cell–cell contacts of myofibroblasts: role in connective tissue remodeling. Thromb. Haemost. 2003;90:993–1002
  13. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G. The myofibroblast: one function, multiple origins. Am. J. Pathol. 2007;170:1807–1816
  14. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat. Rev. Cancer. 2006;6:392–401
  15. Kankuri E, Cholujova D, Comajova M, Vaheri A, Bizik J. Induction of hepatocyte growth factor/scatter factor by fibroblast clustering directly promotes tumor cell invasiveness. Cancer Res. 2005;65:9914–9922
  16. Kunz-Schughart LA, Heyder P, Schroeder J, Knuechel R. A heterologous 3-D coculture model of breast tumor cells and fibroblasts to study tumor-associated fibroblast differentiation. Exp. Cell Res. 2001;266:74–86
  17. Laeeq S, Faust R. Modeling the cholesteatoma microenvironment: Coculture of HaCaT keratinocytes with WS1 fibroblasts induces MMP-2 activation, invasive phenotype, and proteolysis of the extracellular matrix. Laryngoscope. 2007;117:313–318
  18. Lederle W, Stark HJ, Skobe M, Fusenig NE, Mueller MM. Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells. Am. J. Pathol. 2006;169:1767–1783
  19. Mueller MM, Fusenig NE. Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells. Differentiation. 2002;70:486–497
  20. Mueller MM, Fusenig NE. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer. 2004;4:839–849
  21. Orimo A, Weinberg RA. Stromal fibroblasts in cancer. A novel tumor-promoting cell type. Cell Cycle. 2006;5:1597–1601
  22. Pai R, Nakamura T, Moon WS, Tarnawski AS. Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors. FASEB J. 2003;17:1640–1647
  23. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45
  24. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002;30:e36
  25. Rosen EM, Goldberg ID. Regulation of angiogenesis by scatter factor. EXS. 1997;79:193–208
  26. Sappino AP, Skalli O, Jackson B, Schurch W, Gabbiani G. Smooth muscle differentiation in stromal cells of malignant and nonmalignant breast tissues. Int. J. Cancer. 1988;1:707–712
  27. Shephard P, Martin G, Smola-Hess S, Brunner G, Krieg T, Smola H. Myofibroblast differentiation is induced in keratinocyte-fibroblast co-cultures and is antagonistically regulated by endogenous transforming growth factor-beta and interleukin-1. Am. J. Pathol. 2004;164:2055–2066
  28. Sirén V, Salmenperä P, Kankuri E, Bizik J, Sorsa T, Tervahartiala T, et al. Cell–cell contact activation of fibroblasts increases the expression of matrix metalloproteinases. Ann. Med. 2006;38:212–220
  29. Skalli O, Schurch W, Seemaver T, Lagacé R, Montandon D, Pittet B, et al. Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab. Invest. 1989;60:275–285
  30. Tomakidi P, Stark HJ, Herold-Mende C, Bosch FX, Steinbauer H, Fusenig NE, et al. Discriminating expression of differentiation markers evolves in transplants of benign and malignant human skin keratinocytes through stromal interactions. J. Pathol. 2003;200:298–307
  31. Vaheri, A., in press. Nemosis. In: Schwab, M. (Ed.-in-chief), Encyclopedia of Cancer, second ed. Springer.
  32. Vosseler S, Mirancea N, Bohlen P, Mueller MM, Fusenig NE. Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants. Cancer Res. 2005;65:1294–1305
  33. Yang XH, Man XY, Cai SQ, Yao YG, Bu ZY, Zheng M. Expression of VEGFR-2 on HaCaT cells is regulated by VEGF and plays an active role in mediating VEGF induced effects. Biochem. Biophys. Res. Commun. 2006;349:31–38
  34. You L, Kruse FE. Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathway. Invest. Ophthalmol. Vis. Sci. 2002;43:72–81
  35. Zha S, Yegnasubramanian V, Nelson WG, Isaacs WB, De Marzo AM. Cyclooxygenases in cancer: progress and perspective. Cancer Lett. 2004;215:1–20

PII: S1574-7891(08)00122-1

doi: 10.1016/j.molonc.2008.09.002

Molecular Oncology
Volume 2, Issue 4 , Pages 340-348 , December 2008

Article Tools

* Image Usage & Resolution